Rigel Pharmaceuticals Statistics Share Statistics Rigel Pharmaceuticals has 17.94M
shares outstanding. The number of shares has increased by 1.58%
in one year.
Shares Outstanding 17.94M Shares Change (YoY) 1.58% Shares Change (QoQ) 0.05% Owned by Institutions (%) 78.07% Shares Floating 17.44M Failed to Deliver (FTD) Shares 210 FTD / Avg. Volume 0.07%
Short Selling Information The latest short interest is 2.39M, so 13.39% of the outstanding
shares have been sold short.
Short Interest 2.39M Short % of Shares Out 13.39% Short % of Float 13.75% Short Ratio (days to cover) 12.37
Valuation Ratios The PE ratio is 16.91 and the forward
PE ratio is 9.86.
Rigel Pharmaceuticals's PEG ratio is
-0.1.
PE Ratio 16.91 Forward PE 9.86 PS Ratio 1.65 Forward PS 2.2 PB Ratio 89.93 P/FCF Ratio 9.41 PEG Ratio -0.1
Financial Ratio History Enterprise Valuation Rigel Pharmaceuticals has an Enterprise Value (EV) of 298.9M.
EV / Sales 1.67 EV / EBITDA 10.48 EV / EBIT 9.5 EV / FCF 9.51
Financial Position The company has a current ratio of 2.13,
with a Debt / Equity ratio of 18.24.
Current Ratio 2.13 Quick Ratio 2.04 Debt / Equity 18.24 Debt / EBITDA 2.1 Debt / FCF 1.91 Interest Coverage 3.06
Financial Efficiency Return on Equity is 531.78% and Return on Invested Capital is 21.28%.
Return on Equity 531.78% Return on Assets 10.66% Return on Invested Capital 21.28% Revenue Per Employee $1.11M Profits Per Employee $107.93K Employee Count 162 Asset Turnover 1.09 Inventory Turnover 3.11
Taxes Income Tax 881K Effective Tax Rate 4.8%
Stock Price Statistics The stock price has increased by 197.24% in the
last 52 weeks. The beta is 1.21, so Rigel Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.21 52-Week Price Change 197.24% 50-Day Moving Average 20.6 200-Day Moving Average 19.96 Relative Strength Index (RSI) 88.33 Average Volume (20 Days) 281,591
Income Statement In the last 12 months, Rigel Pharmaceuticals had revenue of 179.28M
and earned 17.48M
in profits. Earnings per share was 0.99.
Revenue 179.28M Gross Profit 160.63M Operating Income 24.19M Net Income 17.48M EBITDA 28.51M EBIT 26.28M Earnings Per Share (EPS) 0.99
Full Income Statement Balance Sheet The company has 56.75M in cash and 59.97M in
debt, giving a net cash position of -3.22M.
Cash & Cash Equivalents 56.75M Total Debt 59.97M Net Cash -3.22M Retained Earnings -1.39B Total Assets 206.74M Working Capital 88.76M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 31.47M
and capital expenditures -36K, giving a free cash flow of 31.43M.
Operating Cash Flow 31.47M Capital Expenditures -36K Free Cash Flow 31.43M FCF Per Share 1.79
Full Cash Flow Statement Margins Gross margin is 89.6%, with operating and profit margins of 13.49% and 9.75%.
Gross Margin 89.6% Operating Margin 13.49% Pretax Margin 10.24% Profit Margin 9.75% EBITDA Margin 15.9% EBIT Margin 13.49% FCF Margin 17.53%
Dividends & Yields RIGL does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 5.91% FCF Yield 10.63%
Dividend Details Analyst Forecast The average price target for RIGL is $32,
which is -4.3% lower than the current price. The consensus rating is "Hold".
Price Target $32 Price Target Difference -4.3% Analyst Consensus Hold Analyst Count 5
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number 2.05 Graham Upside -93.87%
Stock Splits The last stock split was on Jun 27, 2024. It was a
backward
split with a ratio of 1:10.
Last Split Date Jun 27, 2024 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -2.68 Piotroski F-Score 7
